| P50 | author | Jürgen Klempnauer | Q93018298 |
| P2093 | author name string | Fatih Noyan | |
| | Michael P Manns | |
| | Elmar Jaeckel | |
| | Roland Schmitt | |
| | Reinhard Schwinzer | |
| | Sonja Kollrich | |
| | Elvira Schulde | |
| | Young-Seon Mederacke | |
| | Florian W Vondran | |
| P2860 | cites work | Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self | Q29619194 |
| | Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. | Q33711255 |
| | Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. | Q34038443 |
| | Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised | Q34075522 |
| | Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance | Q34503328 |
| | Messenger RNA for FOXP3 in the urine of renal-allograft recipients | Q34563002 |
| | Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes | Q34585878 |
| | The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation | Q34922215 |
| | Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes. | Q34969823 |
| | Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly | Q35553381 |
| | Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. | Q53775010 |
| | A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants. | Q54216691 |
| | FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. | Q54530995 |
| | Intragraft Regulatory T Cells in Protocol Biopsies Retain Foxp3 Demethylation and Are Protective Biomarkers for Kidney Graft Outcome | Q59491274 |
| | Variation in numbers of CD4+CD25highFOXP3+T cells with normal immuno-regulatory properties in long-term graft outcome | Q61537310 |
| | Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question | Q73365765 |
| | Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection | Q79740578 |
| | CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients | Q79760444 |
| | The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection | Q79767141 |
| | Dialysis treatment and regulatory T cells | Q82907837 |
| | FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection | Q83263464 |
| | Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells | Q84376771 |
| | Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulation | Q84967566 |
| | Sirolimus vs cyclosporine after induction with basiliximab does not promote regulatory T cell expansion in de novo kidney transplantation: Results from a single-center randomized trial | Q85666929 |
| | Isolation of human antigen-specific regulatory T cells with high suppressive function | Q88207514 |
| | Polyspecificity of T cell and B cell receptor recognition | Q36082439 |
| | Living-donor kidney transplantation: a review of the current practices for the live donor | Q36147557 |
| | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 |
| | Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers | Q36479714 |
| | Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. | Q36906015 |
| | Specificity of T-cell alloreactivity | Q37002818 |
| | Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. | Q37065658 |
| | GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells | Q37304003 |
| | Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy | Q37603816 |
| | Regulatory T cells in the immunodiagnosis and outcome of kidney allograft rejection | Q38120752 |
| | Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes | Q38333256 |
| | Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants. | Q38662974 |
| | Harnessing Advances in T Regulatory Cell Biology for Cellular Therapy in Transplantation | Q39219498 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor. | Q40402774 |
| | CD4+CD25+ regulatory T cells do not significantly contribute to direct pathway hyporesponsiveness in stable renal transplant patients | Q40645870 |
| | Intragraft levels of Foxp3 mRNA predict progression in renal transplants with borderline change. | Q41614286 |
| | End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells | Q42448895 |
| | Two-year follow-up of a prospective study of circulating regulatory T cells in renal transplant patients | Q42459628 |
| | Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes | Q42613015 |
| | Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. | Q42915120 |
| | Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients | Q43133854 |
| | CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 |
| | Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection. | Q45132751 |
| | Peripheral Treg count and it's determinants in unsensitized and sensitized chronic kidney disease patients | Q45147425 |
| | Regulatory T cells for Tolerance | Q47231503 |
| | Association of Higher CD4+ CD25high CD127low , FoxP3+ , and IL-2+ T Cell Frequencies Early After Lung Transplantation With Less Chronic Lung Allograft Dysfunction at Two Years | Q48024329 |
| | Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Facilitating Cell-Enriched Donor Stem Cell Infusion: the importance of durable chimerism | Q50154545 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | kidney transplantation | Q740909 |
| P304 | page(s) | 1021 | |
| P577 | publication date | 2019-01-31 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Transient increase of activated regulatory T cells early after kidney transplantation | |
| P478 | volume | 9 | |